Fig. 4.

β-catenin/c-Myc axis mediates S100A9-driven fatty acid metabolic reprogramming in EGFR-wild-type tumor cells. A β-catenin silencing attenuated intracellular FFA levels induced by mtLC-MSCs. B, C β-catenin silencing reduced transcriptional (B) and protein (C) levels of c-Myc and downstream targets. D c-Myc silencing diminished intracellular FFA levels by mtLC-MSCs. E, F c-Myc silencing decreased the transcriptional (E) and protein (F) expression of downstream targets. G c-Myc or β-catenin silencing, alone or in combination, decreased FASN and GULT1 protein expression. H-I β-catenin translocated to cytoplasmic and nucleus (H), while c-Myc accumulated in nucleus (I) upon mtLC-MSCs-conditioned medium treatment. J, K ChIP-qPCR identified c-Myc binding sites in the promoter of downstream genes in A549 (J) and H1385 (K) cells exposed to mtLC-MSCs-conditioned medium. L FASN silencing reduced intracellular FFA levels upregulated by mtLC-MSCs. M, N Knockdown c-Myc concurrently overexpress β-catenin increased GLUT1, but decreased FASN expression. O Stem-trait protein levels under conditioned medium treatment. P, Q FASN silencing reduced the upregulated transcriptional (P) and protein (Q) levels of stem-trait proteins induced by mtLC-MSCs. NANOG and CD44 transcriptional levels were too low to be detected in H1385 cells (P). Consistent treatment as above described. Statistical results were shown as mean ± SD. *P < 0.05, **P < 0.01, ***P < 0.001, **** P < 0.0001. One-way ANOVA test except panel I (Student’s t-test). FFA, free fatty acid; GLUT1, glucose transporters 1; FASN, fatty acid synthase; ACACA, Acetyl-CoA carboxylase alpha; ACACB, Acetyl-CoA carboxylase beta; ACLY, ATP citrate lyase